No insider purchase over the last 90 days. The latest, by 하경식, was filed 30 Mar 2026.
IMBiologics Corp.: what insiders have been doing
Every trade that managers of IMBiologics Corp. disclose to DART (FSS) is tracked on this page. The company sits in the Health Care sector. 8 insiders have disclosed 13 filings since 2 November 2025.
Both sides are active: 11 purchases and 2 sales, from 8 insiders and 2 insiders respectively. The amount is not disclosed for 13 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The buyers include 2 senior executives and 1 chief executive.
Compared with its exchange (2,655 companies, median 7 filings), a count of 13 filings is above the norm. Over the whole record (from 2026), the tally stands at 11 purchases and 2 sales.
The last insider purchase was made public on 30 March 2026, 225 days ago. Typically, a trade is published a median of 7 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and UCB. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Who traded when
BuySale+2 other insiders
Since the insiders bought
- -76.2%Entry ₩55,300 · Close 30 Oct 2026 ₩13,160
- -80.0%Entry ₩65,700 · Close 30 Oct 2026 ₩13,160
- -80.0%Entry ₩65,700 · Close 30 Oct 2026 ₩13,160
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Financial data
· cache
- Other0DART
- 1,050 sharesKRXDART:20260612000667
- 70,000 sharesKRXDART:20260402003851
- 5,563,208 sharesKRXDART:20260330000541Canonical exit: 18 Jun 2026 (T+90)
- 13,500 sharesShareKRXDART:20260327000564Canonical exit: 18 Jun 2026 (T+90)
- 1,622,190 sharesShareKRXDART:20260327001210Canonical exit: 18 Jun 2026 (T+90)
- 2,400,000 sharesShareKRXDART:20260327000562Canonical exit: 18 Jun 2026 (T+90)
- 896,052 sharesKRXDART:20260327000992Canonical exit: 18 Jun 2026 (T+90)
- 1,065,294 sharesKRXDART:20260327001218Canonical exit: 18 Jun 2026 (T+90)
- 839,456 sharesKRXDART:20260327001425Canonical exit: 18 Jun 2026 (T+90)
- 800,798 sharesKRXDART:20260327000698Canonical exit: 18 Jun 2026 (T+90)
- 1,622,190 sharesKRXDART:20260327001184Canonical exit: 18 Jun 2026 (T+90)
- 300,000 sharesShareKRXDART:20260327000565Canonical exit: 18 Jun 2026 (T+90)
- 839,456 sharesKRXDART:20260326001311Canonical exit: 18 Jun 2026 (T+90)
14 of 14 declarations
About IMBiologics Corp.
아이엠바이오로직스 is a company in the health and pharmaceutical sector, listed on the XKRX market. It specializes in the development of innovative biological solutions.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
